gramnegative strains s maltophilia atcc 17808 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
93
Structured Review
ATCC
gramnegative strains s maltophilia atcc 17808
Gramnegative Strains S Maltophilia Atcc 17808, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gramnegative+strains+s+maltophilia+atcc+17808/Stenotrophomonas+maltophilia+formerly+xanthomonas/pm41330228-44-36-40
Average 93 stars, based on 1 article reviews
Gramnegative Strains S Maltophilia Atcc 17808, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gramnegative+strains+s+maltophilia+atcc+17808/Stenotrophomonas+maltophilia+formerly+xanthomonas/pm41330228-44-36-40
Average 93 stars, based on 1 article reviews
gramnegative strains s maltophilia atcc 17808 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
In Vitro:Article Title: Development of cationic Pyridinium-Oxazolidinone derivatives as antibacterial agents. Article Snippet: Drug-resistant bacteria and biofilm-associated infections remain major challenges in anti-infective therapy, contributing to high morbidity and mortality and emphasizing the need to develop novel antimicrobial agents with a low potential to induce resistance.. Toward this, quaternization of compounds has become a viable molecular design approach for developing antibacterial agents.. In this study, we report the design, synthesis, and antibacterial evaluation of a series of novel ring-C-modified quaternary ammonium oxazolidinone derivatives bearing various lipophilic substituents (alkyland aryl-moieties). Activity Assay:Article Title: Development of cationic Pyridinium-Oxazolidinone derivatives as antibacterial agents. Article Snippet: Drug-resistant bacteria and biofilm-associated infections remain major challenges in anti-infective therapy, contributing to high morbidity and mortality and emphasizing the need to develop novel antimicrobial agents with a low potential to induce resistance.. Toward this, quaternization of compounds has become a viable molecular design approach for developing antibacterial agents.. In this study, we report the design, synthesis, and antibacterial evaluation of a series of novel ring-C-modified quaternary ammonium oxazolidinone derivatives bearing various lipophilic substituents (alkyland aryl-moieties). Concentration Assay:Article Title: Development of cationic Pyridinium-Oxazolidinone derivatives as antibacterial agents. Article Snippet: Drug-resistant bacteria and biofilm-associated infections remain major challenges in anti-infective therapy, contributing to high morbidity and mortality and emphasizing the need to develop novel antimicrobial agents with a low potential to induce resistance.. Toward this, quaternization of compounds has become a viable molecular design approach for developing antibacterial agents.. In this study, we report the design, synthesis, and antibacterial evaluation of a series of novel ring-C-modified quaternary ammonium oxazolidinone derivatives bearing various lipophilic substituents (alkyland aryl-moieties). Membrane:Article Title: Development of cationic Pyridinium-Oxazolidinone derivatives as antibacterial agents. Article Snippet: Drug-resistant bacteria and biofilm-associated infections remain major challenges in anti-infective therapy, contributing to high morbidity and mortality and emphasizing the need to develop novel antimicrobial agents with a low potential to induce resistance.. Toward this, quaternization of compounds has become a viable molecular design approach for developing antibacterial agents.. In this study, we report the design, synthesis, and antibacterial evaluation of a series of novel ring-C-modified quaternary ammonium oxazolidinone derivatives bearing various lipophilic substituents (alkyland aryl-moieties). |